-
Document de presse | 2017.12.14
Sanofi and the Institut Pasteur reward five researchers for their major contributions in the service of human health
Paris, France – December 13th 2017 - Sanofi and the Institut Pasteur presented the Sanofi - Institut Pasteur Awards for the sixth year in a row.Five internationally recognized researchers were rewarded for their work in two major fields with implications for global health: Immunology and Microbiology & Infection. The National Junior award winnersDocteur Fabrizia Stavru – Bacteria-Cell...
-
News | 2018.01.11
Frédéric Tangy, expert from the Institut Pasteur, talks about vaccines of today and tomorrow
In 2017, vaccinology expert Frédéric Tangy was recognized by the Institut Pasteur for his work on the Measles Platform and was elected as a member of the US National Academy of Inventors. As the Institut Pasteur enters its 130th year – it will be celebrating its 130th anniversary on November 14, 2018 – it seemed like a good opportunity to ask the scientist to tell us a little more about his...
-
Document de presse | 2019.01.24
The new Institut Pasteur strategic plan for 2019-2023
After taking office as President of the Institut Pasteur in January 2018, Professor Stewart Cole embarked on the development of a new strategic plan for the Institut Pasteur for the period 2019-2023. On December 21, 2018, the Board of Directors unanimously adopted this ambitious yet realistic action plan for the next five years.Three priority scientific areas have been identified: • emerging...
-
Document de presse | 2021.01.19
COVID-19: a lentiviral vaccine candidate for intranasal administration provides sterilizing protection in animal models
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the results of tests, in two preclinical models, of a COVID-19 vaccine candidate using a lentiviral vector administered by nasal route. Their study demonstrates that the vaccine candidate induces antibody response with strong neutralizing activity against SARS-CoV-2, as well as...
-
Document de presse | 2021.01.25
COVID-19: progress update on the Institut Pasteur's scientific response and vaccine candidate research programs
Since early 2020, the Institut Pasteur has been engaged in research in several of its areas of scientific expertise, including virology, diagnostics, pathophysiology, epidemiology, modeling, therapeutic research and vaccine research. A number of research programs to find a vaccine for SARS-CoV-2, the virus responsible for the COVID-19 epidemic, are under way. In light of the intermediate results...
-
Document de presse | 2021.04.14
Genetic admixture in the South Pacific: from Denisovans to the human immune response
Describing the genetic diversity of human populations is essential to improve our understanding of human diseases and their geographical distribution. However, the vast majority of genetic studies have been focused on populations of European ancestry, which represent only 16% of the global population. Scientists at the Institut Pasteur, Collège de France, and CNRS have looked at understudied...
-
Portrait | 2022.03.29
Jean-Claude Manuguerra: viruses, animals and humans
It all started with a veterinarian and a cross-eyed lionJean-Claude Manuguerra was 7 when he decided that he wanted to become a veterinarian, to "save animals" – like in the TV series Daktari, which he was an avid fan of at the time. In the series, Dr. Marsh Tracy was a vet who cared for local animals and ran the Wameru Study Center for Animal Behavior in Kenya. Marsh Tracy was aided in his day-...
-
Portrait | 2024.03.05
Carla Saleh, leading the fight against viruses and inequality
When Carla Saleh arrived in France from Argentina aged 25 as a young scientist, she didn't speak a word of French. She now leads her own research unit at the Institut Pasteur.Her goal is to make mosquitoes intolerant to viruses. She is passionate about science, determined to tackle all forms of inequality and discrimination, and always keen to encourage anyone – especially girls and women – with...
-
News | 2024.03.25
Tackling flaviviruses and preparing the European Union for emerging threats
The genus flavivirus includes several human pathogens, such as Zika, dengue, West Nile virus (WNV) and yellow fever virus, which persist as major threats to global public health. Yellow4FLAVI, coordinated by Giovanna Barba-Spaeth, Institut Pasteur, comprises 13 partner institutions and is supported by the European Union with with € 8 million. The aim is to use the 17D yellow fever vaccine as...
-
Document de presse | 2024.03.28
Inauguration in Brazil of the Institut Pasteur de São Paulo, member of the Pasteur Network
On March 27, 2024, the Institut Pasteur de São Paulo was inaugurated by French President, Emmanuel Macron. As a member of the Pasteur Network, this institute, founded by the Institut Pasteur and the University of São Paulo, conducts international-level research in the field of health biology to further understanding of diseases and their impact on human health, especially in the context of...
